Achieved first-ever RNA editing in humans in RestorAATion-2 trial of WVE-006 (GalNAc-AIMer) in alpha-1 antitrypsin deficiency and announced ... pathways to accelerated approval and open to Wave’s plan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback